For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...

For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable.

Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., autoimmunity) can cause permanent hair loss, a new study shows.

When it involves the beard, doctors call it alopecia barbae. Fungi cause ringworm, which is a common skin infection. It can affect any part of the body. When it affects the beard, it is known as ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

Higher rates of venous thromboembolism, lymphoma, and infections were observed in those with atopic dermatitis and psoriasis vs control patients.

ORLANDO, FLA. — Janus kinase (JAK) inhibitors have revolutionized the treatment of alopecia areata (AA), and more drugs in this class are still in development for AA. However, a new therapy with ...

ORLANDO -- More than 80% of patients with moderate or severe atopic dermatitis (AD) had at least 75% improvement after 12 ...

placebo in adults with severe alopecia areata, according to phase 3 data presented here. Oral ivarmacitinib significantly induced hair regrowth at 24 weeks compared with placebo in adults with ...

Reported infections include ... In patients with RA or alopecia areata (AA), avoid initiation or interrupt Olumiant treatment in patients with an ANC <1000 cells/mm 3. In patients with COVID ...

Significantly more patients receiving baricitinib 2 mg, 4 mg had SALT score ≤20, ≤10 versus placebo at week 36 ...